-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Downgrades Pacira BioSciences to Hold

Benzinga·10/08/2026 15:34:02
Needham analyst Serge Belanger downgrades Pacira BioSciences (NASDAQ:PCRX) from Buy to Hold.